ROP — Roche Holding AG Share News
0.000.00%
Last trade - 00:00- CH₣254.44bn
- CH₣276.23bn
- CH₣61.52bn
Europe risks falling further behind in medicine race, warns Roche CEO
Brief: Roche Expects Blockbuster Cancer Pill Launch By Year End - Bloomberg News
Brief: Roche CEO In Interview: U.S. MFN Policies Are Fair, Offer Needed Change To Pharma Drug Pricing Systems
Roche Q1 sales down on forex effects (updated)
Roche Q1 sales down on forex effects
Swiss stocks - Factors to watch on April 23
Roche submits multiple sclerosis drug fenebrutinib to regulators despite patient deaths (updated)
Roche submits multiple sclerosis drug fenebrutinib to regulators despite patient deaths
Brief: Roche’s fenebrutinib significantly reduced relapses in RMS
Brief: Genentech's Enspryng Cuts Relapse Risk 68%, Shows Potential as First MOGAD Treatment
Table: Swiss trade surplus at CHF 3.18 bln in March
Brief: FDA Accepts Application For Roche's Gazyva/Gazyvaro For Treatment Of Lupus
Roche launches new Elevidys study after feedback from European regulator
Weight loss drugs face first economic stress test
Brief: Roche Receives CE Mark For New Elecsys Nfl Blood Test To Detect Neuroinflammation In Multiple Sclerosis
C4 Therapeutics, Roche expand partnership with new cancer deal worth over $1 billion
C4 Therapeutics gains as Roche signs up to $1 bln cancer drug deal
Brief: C4 Therapeutics Expands Long-Term Partnership With Roche Through New Collaboration Agreement Focused On Discovering And Developing Degrader-Antibody Conjugates (DACs)
Star anise gives chipmakers a recipe for shortages